380
Participants
Start Date
May 13, 2022
Primary Completion Date
November 23, 2022
Study Completion Date
November 23, 2022
Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation. Participants will instill 1 drop of the assigned investigational drug in each eye 4 times a day approximately 4 hours apart for up to 4 consecutive weeks.
Lumify® (brimonidine tartrate ophthalmic solution 0.025%)
Lumify® (brimonidine tartrate ophthalmic solution 0.025%). Participants will instill 1 drop of the assigned investigational drug in each eye 4 times a day approximately 4 hours apart for up to 4 consecutive weeks.
Bausch Site 03, Shelby
Bausch Site 02, Memphis
Bausch Site 05, Louisville
Bausch Site 04, Colorado Springs
Bausch Site 06, Clinton
Bausch Site 01, Andover
Bausch & Lomb Incorporated
INDUSTRY